{"id":172,"date":"2021-08-05T06:25:31","date_gmt":"2021-08-05T06:25:31","guid":{"rendered":"https:\/\/bioacq.wpengine.com\/?page_id=172"},"modified":"2021-08-05T06:49:52","modified_gmt":"2021-08-05T06:49:52","slug":"corporate-governance","status":"publish","type":"page","link":"https:\/\/bioacq.com\/?page_id=172","title":{"rendered":"Corporate Governance"},"content":{"rendered":"\n
\n
\n
\n
\n

Code of Ethics<\/h3>\n\n\n\n
\n
Download<\/a><\/div>\n<\/div>\n<\/div><\/div>\n\n\n\n
\n

Compensation Committee Charter<\/h3>\n\n\n\n
\n
Download<\/a><\/div>\n<\/div>\n\n\n\n
<\/div>\n<\/div><\/div>\n\n\n\n
\n

Audit Committee Charter<\/h3>\n\n\n\n
\n
Download<\/a><\/div>\n<\/div>\n\n\n\n

<\/p>\n<\/div><\/div>\n<\/div><\/div>\n<\/div><\/div>\n<\/div><\/div>\n\n\n\n

<\/p>\n\n\n\n

\n
\n
\n

Cautionary Note Concerning Forward-Looking Statements<\/em><\/strong><\/p>\n\n\n\n

This communication contains statements that constitute \u201cforward-looking statements,\u201d including with respect to the\u00a0anticipated use of the net proceeds from the\u00a0Company\u2019s initial public\u00a0offering. No assurance can be given that the\u00a0net proceeds will be used as indicated. Forward-looking statements are subject to numerous risks and uncertainties, many of which are beyond the control of the Company, including those set forth in the Risk Factors section of the Company\u2019s\u00a0prospectus relating to the offering, which is\u00a0filed with the U.S. Securities and Exchange Commission (\u201cSEC\u201d). Copies are available on the SEC\u2019s\u00a0website, www.sec.gov. The Company undertakes no obligation to update\u00a0its forward-looking\u00a0statements, except as required by law.<\/em><\/em><\/p>\n\n\n\n

No Offer or Solicitation<\/em><\/strong><\/p>\n\n\n\n

The information on this website shall not constitute a solicitation of a proxy, consent or authorization with respect to any securities or in respect of the proposed transaction. The information on this website shall also not constitute an offer to sell or the solicitation of an offer to buy any securities, nor shall there be any sale of securities in any states or jurisdictions in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such jurisdiction. No offering of securities shall be made except by means of a prospectus meeting the requirements of section 10 of the Securities Act of 1933, as amended.<\/em><\/p>\n<\/div><\/div><\/div>\n<\/div><\/div>\n<\/div><\/div>\n","protected":false},"excerpt":{"rendered":"","protected":false},"author":2,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"footnotes":""},"class_list":["post-172","page","type-page","status-publish","hentry"],"featured_image_src":null,"featured_image_src_square":null,"_links":{"self":[{"href":"https:\/\/bioacq.com\/index.php?rest_route=\/wp\/v2\/pages\/172","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/bioacq.com\/index.php?rest_route=\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/bioacq.com\/index.php?rest_route=\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/bioacq.com\/index.php?rest_route=\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/bioacq.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=172"}],"version-history":[{"count":0,"href":"https:\/\/bioacq.com\/index.php?rest_route=\/wp\/v2\/pages\/172\/revisions"}],"wp:attachment":[{"href":"https:\/\/bioacq.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=172"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}